COYA Treg-directed combo therapies show early promise in ALS, FTD
TradingView News reports COYA’s Treg-directed combination therapies show promising early clinical signals in ALS and FTD, with key data expected in 2027.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.